Condition: Radiation-induced Dermatitis · Sponsor: West China Hospital
To evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
This description comes directly from the study's public registry record.
Xingchen Peng · +86 18980606753 · pxx2014@163.com
Ruiwan Yuan · yuanruiwan@outlook.com
Always discuss trial participation with your own doctor first.
| Sichuan University West China Hospital, Chengdu, Sichuan | Chengdu, Sichuan, China | Recruiting |
| Sichuan University West China Hospital | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07353671